LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
3.43
EUR
0.12
EUR
3.54 %
21.08.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.88 USD | -0.01 USD | -0.19 % |
|---|
| Vortag | 3.89 USD | Datum | 20.08.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Stellar ETP | CH1109575535 | 30.45% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 27.12% | |
| 21Shares Aave ETP | CH1135202120 | 27.06% | |
| 21shares Morpho ETP | CH1506167027 | 19.84% | |
| 21Shares Chainlink ETP | CH1100083471 | 16.91% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 6.52% | |
| 21Shares Jupiter ETP | CH1480821383 | 0.03% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -0.30% | |
| 21Shares Maple Finance ETP | CH1495416989 | -4.59% | |
| 21Shares Injective Staking ETP | CH1360612134 | -6.75% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 153.63% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 82.95% | |
| 21shares Morpho ETP | CH1506167027 | 54.19% | |
| 21Shares Injective Staking ETP | CH1360612134 | 43.06% | |
| 21Shares Ondo ETP | CH1396389921 | 40.55% | |
| 21Shares Jupiter ETP | CH1480821383 | 33.92% | |
| 21Shares Pendle ETP | CH1495416997 | 30.14% | |
| 21Shares Chainlink ETP | CH1100083471 | 28.68% | |
| 21Shares Bittensor ETP | CH1495416971 | 25.00% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 10.91% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | 13.23% | |
| 21Shares Binance BNB ETP | CH0496454155 | -24.13% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -25.49% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -33.54% | |
| 21Shares Bitcoin ETP | CH0454664001 | -34.45% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -63.34% | |
| 21Shares Dogecoin ETP | CH1431521033 | -64.08% | |
| 21Shares XDC Network ETP | CH1464217285 | -65.80% | |
| 21Shares Injective Staking ETP | CH1360612134 | -66.15% | |
| 21Shares Sui Staking ETP | CH1360612159 | -78.04% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 122.53% | |
| 21Shares Stellar ETP | CH1109575535 | 84.53% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 68.27% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 48.42% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 26.89% | |
| 21Shares Sui Staking ETP | CH1360612159 | -6.75% | |
| 21Shares Injective Staking ETP | CH1360612134 | -76.45% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 837’531.20 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 21.08.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 97.65 | |
| Performance 2 Jahre | 80.09 | |
| Performance 3 Jahre | 55.31 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
ETP Kategorievergleich
| Name | 1J Perf. | |
|---|---|---|
| ARK Genomic Revolution UCITS ETF Class A USD Accumulation | 98.29 |